Autophosphorylation of the carboxyl-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants-Reference-Cited by-同舟云学术

Autophosphorylation of the carboxyl-terminal domain is not required for oncogenic transformation by lung-cancer derived EGFR mutants

Author:

Cho Jeonghee¹²³^ORCID,Kim Sujin¹,Du Jinyan²³⁴,Meyerson Matthew²³⁵⁶

Affiliation:

1. Department of Nanobiomedical Science; Dankook University; Cheonan 31116 Republic of Korea

2. Department of Medical Oncology; Dana-Farber Cancer Institute; Boston MA 02115

3. Center for Cancer Genome Discovery; Dana-Farber Cancer Institute; Boston MA 02115

4. Discovery, Merrimack Pharmaceuticals; Cambridge MA 02139

5. The Broad Institute of MIT and Harvard; Cambridge MA 02112

6. Department of Pathology; Harvard Medical School; Boston MA 02115

Funder

Korea Health Industry Development Institute

Ministry of Health & Welfare, Republic of Korea

National Research Foundation of Korea (NRF), Korea government (MEST)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference32 articles.

4. Driven by mutations: the predictive value of mutation subtype in EGFR-mutated non-small cell lung cancer;Castellanos;J Thorac Oncol,2016

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献